Open an account

UiPath

PATH · NYSE

$13.43+$0.31 (+2.36%)TodayMarket closed ·
Prev close $13.12

About PATH

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The company is headquartered in New York City, New York and currently employs 3,981 full-time employees. The company went IPO on 2021-04-21. The company is focused on building and managing automations, starting with computer vision technology and user interface automation in its initial robotic process automation offering. Its AI-powered UiPath Platform offers a robust set of capabilities that allows its customers to discover opportunities for automation, automate using a digital workforce that seamlessly collaborates with humans, and operate a mission-critical automation program at scale. The company enables employees to quickly build automations for both existing and new processes and to automate a range of actions including logging into applications, moving folders, filling in forms, reading emails and others. Its platform allows users to design and combine UI automations, API integrations and AI-based document understanding in a single workflow.

Employees
3,981
Headquarters
New York City, New York
Listed
Apr 21, 2021
Sector
Information Technology
Industry
Software
Website
uipath.com

PATH key statistics

Market cap
6.84B
Price-earnings ratio
19.58
Dividend yield
—
Average volume
33.34M
Volume
31.19M
Open price
$13.12
High today
$13.62
Low today
$13.12
52 Week high
$19.84
52 Week low
$9.20

UiPath (PATH) at a glance

UiPath (PATH) last traded at $13.43, with a market cap of 6.84B and a price-to-earnings ratio of 19.58.

Today the stock has traded between $13.12 and $13.62. The current price is 2.4% above the day's low and 1.4% below its high.

Volume so far is 31.19M shares, in line with the average of 33.34M shares a day.

Over the past year UiPath has ranged from $9.20 to $19.84, and now sits 40% of the way up that range.

UiPath met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY27 it reported $0.15 per share against an estimate of $0.1517.

The average analyst price target is $15.73, 17.1% above the current price, from 16 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

13%of 16 analyst ratings say Buy
  • Buy12.5%
  • Hold75.0%
  • Sell12.5%
Price target · 21 analystsAvg $15.73
Low
$10.10
Now
$13.43
High
$24.15

PATH earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 26.8% on average.

  1. Q2 FY25: reported $0.04 per share against an estimate of $0.0334
  2. Q3 FY25: reported $0.16 per share against an estimate of $0.149
  3. Q4 FY25: reported $0.26 per share against an estimate of $0.2046
  4. Q2 FY26: reported $0.15 per share against an estimate of $0.0817
  5. Q3 FY26: reported $0.16 per share against an estimate of $0.149
  6. Q4 FY26: reported $0.30 per share against an estimate of $0.2597
  7. Q1 FY27: reported $0.15 per share against an estimate of $0.1628
  8. Q2 FY27: reported $0.15 per share against an estimate of $0.1517

PATH news

  • 10 Information Technology Stocks With Whale Alerts In Today’s Session

  • Press releaseGlobe Newswire

    The Billion-Dollar Defense AI Revolution Is Here: Autonomous Mission Intelligence Set to Transform Modern Warfare

  • Press releaseBusiness Wire

    UiPath Recognized as a Leader in the 2026 Gartner® Magic Quadrant™ for Agentic Software Quality Assurance Platforms

  • Press releaseBusiness Wire

    UiPath Named a Leader and Star Performer in the Everest Group Process Orchestration Products PEAK Matrix® Assessment 2026

  • Press releaseBusiness Wire

    UiPath Recognized as a Leader in Analyst Evaluation for Adaptive Process Orchestration Software

  • Press releaseBusiness Wire

    UiPath Test Cloud Now Available on Oracle Marketplace

  • Press releaseBusiness Wire

    PLDT Wins Silver Award at 2026 UiPath AI Breakthrough Awards for Agentic AI-Driven Enterprise Transformation

  • Press releaseBusiness Wire

    UiPath Joins NCQA AI Learning Collaborative to Advance Responsible AI in Healthcare

Similar companies

Companies in the same industry as UiPath

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.